Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04412629
Title Cabozantinib in High Grade Neuroendocrine Neoplasms
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Washington University School of Medicine
Indications

neuroendocrine tumor

Therapies

Cabozantinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Washington University School of Medicine Recruiting Saint Louis Missouri 63110 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field